GSK· @GSK · X·· 12 天前AI 评分23
AI 导读
#投资者与#媒体新闻:在#TLM26上,我们公布了在慢性乙型肝炎(CHB)、代谢功能障碍相关脂肪性肝炎(MASH)和酒精相关肝病(ALD)领域肝病管线的最新进展。 🔗 了解更多:https://gsk.to/3Uct1hi
正文
#News for #Investors and #Media: At #TLM26 we’re unveiling our latest advancements across our hepatology pipeline for chronic hepatitis B (CHB), metabolic dysfunction-associated steatohepatitis (MASH), and alcohol-related liver disease (ALD).
🔗 Find out more: https://gsk.to/3Uct1hi
来源:GSK · x.com